How retroviruses select their genomes

Nature Reviews Microbiology

Volumn 3, Issue 8, 2005, Pages 643-655

  D'Souza, Victoria ^a   Summers, Michael F ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CAPSID PROTEIN; DACTINOMYCIN; EXPORTIN 1; GAG PROTEIN; GENOMIC RNA; MATRIX PROTEIN; MESSENGER RNA; NUCLEOCAPSID PROTEIN; POL PROTEIN; RETROVIRUS VECTOR; REV PROTEIN; VIRUS RNA; VPR PROTEIN;

5' UNTRANSLATED REGION; ANTIVIRAL ACTIVITY; BOVINE LEUKEMIA VIRUS; DIMERIZATION; DNA PACKAGING; FELINE IMMUNODEFICIENCY VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MASON PFIZER MONKEY VIRUS; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; RETROVIRUS; RETROVIRUS INFECTION; REVIEW; RNA CONFORMATION; RNA SPLICING; RNA STRUCTURE; ROUS SARCOMA ONCOVIRUS; VIRAL GENE THERAPY; VIRION; VIRUS ASSEMBLY; VIRUS GENOME; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; BASE SEQUENCE; GENE PRODUCTS, GAG; GENOME, VIRAL; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MOLONEY MURINE LEUKEMIA VIRUS; NUCLEIC ACID CONFORMATION; RETROVIRIDAE; RNA, VIRAL; VIRUS ASSEMBLY;

BOVINE LEUKEMIA VIRUS; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MASON-PFIZER MONKEY VIRUS; MIRIDAE; MOLONEY MURINE LEUKEMIA VIRUS; ROUS SARCOMA VIRUS;

EID: 20344368389     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1210     Document Type: Review

References (166)

1. Coffin, J. M., Hughes, S. H. & Vermus, H. E. Retroviruses (Cold Spring Harbor Laboratory Press, Plainview, 1997).
2. Nelson, P. N. et al. Demystified. Human endogenous retrovinises. J. Clin. Pathol. Mol. Pathol. 56, 11-18 (2002).
3. Bender, W. et al. High-molecular-weight RNAs of AKR, NZB and wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures. J. Virol. 25, 888-896 (1978).
4. Murti, K. G., Bondurant, M. & Tereba, A. Secondary structural features in the 70S RNAs of Moloney murine leukemia and Rous sarcoma viruses as observed by electron microscopy. J. Virol. 37, 411-419 (1981).
5. Fu, W. & Rein, A. Maturation of dimeric viral RNA of Moloney murine leukemia virus. J. Virol. 67, 5443-5449 (1993).
6. Muriaux, D., Mirro, J., Harvin, D. & Rein, A. RNA is a structural element in retrovirus particles. Proc. Natl Acad. Sci. USA 98, 5246-5251 (2001).
7. Hu, W. S. & Temin, H. M. Retroviral recombination and reverse transcription. Science 250, 1227-1233 (1990).
8. Berkowitz, R., Fisher, J. & Goff, S. P. RNA packaging. Curr. Top. Microbiol. Immun. 214, 177-218 (1996).
9. Rein, A. Retroviral RNA packaging: a review. Arch. Virol. 9, 513-522 (1994).
10. Jewell, N. A. & Mansky, L. M. In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly. J. Gen. Virol. 81, 1889-1899 (2000).
11. Paillart, J.-C., Shehu-Xhilaga, M., Marquet, R. & Mak, J. Dimerization of retroviral RNA genomes: an inseparable pair. Nature Rev. Microbiol. 2, 461-472 (2004).
12. Russell, R. S., Liang, C. & Weinberg, M. A. Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably? Retrovirology 1, 23 (2004).
13. Greatorex, J. The retroviral RNA dimer linkage: different structures may reflect different roles. Retrovirology 1, 22 (2004).
14. Berkowitz, R. D., Ohagen, A.. Hoglund, S. & Goff, S. P. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J. Virol. 69, 6445-6456 (1995).
15. Zhang, Y. & Barklis, E. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J. Virol. 69, 5716-5722 (1995).
16. Dupraz, P. & Spahr, P.-F. Specificity of Rous sarcoma virus nucleocapsid protein in genomic RNA packaging. J. Virol. 66, 4662-4670 (1992).
17. Rizvi, T. A. & Panganiban, A. T. Simian immunodeficiency virus RNA is efficiently encapsidate by human immunodeficiency virus type 1 particles. J. Virol. 67, 2681-2688 (1993).
18. Yin, P. D. & Hu, W.-S. RNAs from genetically distinct retroviruses can copackage and exchange genetic information in vivo. J. Virol. 71, 6237-6242 (1997).
19. Certo, J. L., Shook, B. F., Yin, P. D., Snider, J. T. & Hu, W.-S. Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA. J. Virol. 72, 5408-5413 (1998).
20. Kaye, J. F. & Lever, A. M. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of gag in RNA encapsidation. J. Virol. 72, 5877-5885 (1998).
21. Poon, D. T. K., Li, g. & Aldovini, A. Nucleocapsid and matrix protein contributions to selective Human Immunodeficiency Virus Type 1 genomic RNA packaging. J. Virol. 72, 1983-1993 (1998).
22. Wang, H., Norris, K. M. & Mansky L. M. Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging. J. Virol. 77, 9431-9438 (2003).
23. Lee, E.-G., Yeo, A., Kraemer, B., Wickens, M. & Linial, M. L. The Gag domains required for avian retroviral RNA encapsidation determined by using two independent assays. J. Virol. 73, 6282-6292 (1999).
24. Henderson, L. E., Copeland, T. D., Sowder, R. C., Smythers, G. W. & Oroslzan, S. Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. J. Biol. Chem. 256, 8400-8406 (1981).
25. Green, L. M. & Berg, J. M. A ratroviral Cys-Xaa2-Cys-Xaa4-His-Xaa4-Cys peptide binds metal ions: spectroscopic studies and a proposed three-dimensional structure. Proc. Natl Acad. Sci. USA 86, 4047-4051 (1989).
26. Summers, M. F. et al. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1, 563-574 (1992).
27. Méric, C., Gouilloud, E. & Spahr, P.-F. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His Boxes. J. Virol. 62, 3328-3333 (1988).
28. Méric, C. & Goff, S. P. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J. Virol. 63, 1558-1568 (1989).
29. Gorelick, R. J., Henderson, L. E., Hanser, J. P. & Rein, A. Point mutants of Moloney murine leukemia virus that fail to packageviral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc. Natl Acad. Sci. USA 85, 8420-8424 (1988).
30. Rice, W. G. et al. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature 361, 473-475 (1993).
31. 1H NMR. EMBO J. 11, 3059-3065 (1992).
32. Summers, M. F., South, T. L., Kim, B. & Hare, D. R. High-resolution structure of an HIV zinc fingerlike domain via a new NMR-based distance geometry, approach. Biochemistry 29, 329-340 (1990).
33. Newman, J. L., Butcher, E. W., Patel, D. T., Makhaylenko, Y. & Summers, M. F. Flexibility in the P2 domain of the HIV-1 Gag polyprotein. Protein Sci. 13, 2101-2107 (2004).
34. Lee, B. M., De Guzman, R. N., Turner, B. G., Tandra, N. & Summers, M. F. Dynamical behavior of the HIV-1 nucleocapsid protein. J. Mol. Biol. 279, 633-649 (1998).
35. Banks, J. D. & Linial, M. L. Secondary structure analysis of a minimal avian leukosis-sarcoma virus packaging signal. J. Virol. 74, 456-464 (2000).
36. Mann, R. & Baltimore, D. Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNA. J. Virol. 54, 401-407 (1985).
37. Watanabe, S. & Temin, H. M. Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5′ long terminal repeat and the start of the gag gene. Proc. Natl Acad. Sci. USA 79, 5986-5990 (1982).
38. Lever, A. M. L., Göttlinger, H. G., Haseltine, W. A. & Sodroski, J. G. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 63, 4085-4087 (1989).
39. Mansky, L. M., Krueger, A. E. & Temin, H. M. The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5′ end of the gag gene. J. Virol. 69, 3282-3289 (1995).
40. Browning, M. T., Mustafa, F., Schmidt, R. D., Lew, K. A. & Rizvi, T. A. Delineation of sequences important for efficient packaging of feline immunodeficiency virus RNA. J. Gen. Virol. 84, 621-627 (2003).
41. Kaye, J. F. & Lever, A. M. Human innumodeficiency virus type-1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation. J. Virol. 73, 3023-3031 (1999).
42. Mustafa, F., Lew, K. A., Schmidt, R. D., Browning, M. T. & Rizvi, T. A. Mutational analysis of the predicted secondary RNA structure of the Mason-Pfizer monkey virus packaging signal. Virus Res. 99, 35-46 (2004).
43. Hayashi, T., Ueno, Y. & Okamoto, T. Elucidation of a conserved RNA stem-loop structure in the packaging signal of human immunodeficiency virus type 1. FEBS Lett. 327, 213-218 (1993).
44. Mougel, M. & Barklis, E. A role for two hairpin structures as a core RNA encapsidation signal in murine leukemia virus virions. J. Virol. 71, 8061-8065 (1997).
45. Adam, M. A. & Miller, A. D. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J. Virol. 62, 3802-3806 (1988).
46. Aschoff, J. M., Foster, D. & Coffin, J. M. Point mutations in the avian sarcoma/leukosis virus 3′ untranslated region result in a packaging defect. J. Virol. 73, 7421-7429 (1999).
47. Yu, S. S., Kim, J.-M. & Kim, S. The 17 nucleotides downstream from the env gene stop codon are important for Murine Leukemia Virus packaging. J. Virol. 74, 8775-8780 (2000).
48. Peters, G. & Hu, J. Reverse transcriptase as the major determinant for selective packaging of tRNAs into avian sarcoma virus particles. J. Virol. 36, 692-700 (1980).
49. Katz, R. A., Terry, R. W. & Skalka, A. M. A conserved cis-acting sequence in the 5′ leader of avian sarcoma virus RNA is required for packaging. J. Virol. 59, 163-167 (1986).
50. Greatorex, J. & Lever, A. Retroviral RNA dimer linkage. J. Gen. Virol. 79, 2877-2882 (1998).
51. Paillart, J.-C., Marquet, R., Skripkin, E., Ehresmann, C. & Ehresmann, B. Dimerization of retroviral genomic RNAs: structural and functional implications. Biochimie 78, 639-653 (1996).
52. Berkhout, B. Structure and function of the human immunodeficiency virus leader RNA. Prog. Nucl. Acid Res. Mol. Biol. 54, 1-34 (1996).
53. Laughrea, M. et al. Mutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization. J. Virol. 71, 3397-3406 (1997).
54. McBride, M. S. & Panganiban, A. T. Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo. J. Virol. 71, 2050-2058 (1997).
55. Levin, J. G., Grimley, P. M., Ramseur, J. M. & Berezesky, I. K. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J. Virol. 14, 152-161 (1974).
56. Hibbert, C. S., Mirro, J. & Rein, A. mRNA molecules containing MLV packaging signals are encapsidated as dimers. J. Virol. 78, 10927-10938 (2004).
57. Housset, V., De Rocquigny H., Roques, B. P. & Darlix, J.-L. Basic amino acids flaniking the zinc finger of Moloney munine leukemia virus nucleocapsid protein NCp10 are critical for virus infectivity. J. Virol. 67, 2537-2545 (1993).
58. Sakuragi, J.-I., Shioda, T. & Panganiban, A. T. Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions. J. Virol. 75, 2557-2565 (2001).
59. Sakuragi, J.-I., Iwamoto, A. & Shioda, T. Dissociation of genome dimerization from packaging functions and virion maturation of Human Immunodeficiency Virus Type 1. J. Virol. 76, 959-967 (2002).
60. Mann, R., Mulligan, R. C. & Baltimore, D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33, 153-159 (1983).
61. Schwartzberg, P., Colicelli, J., Gordon, M. L. & Goff, S. Mutations in the gag gene of Moloney murine leukemia virus: effects on production of virions and reverse transcriptase. J. Virol. 49, 918-924 (1984).
62. Murphy, J. E. & Goff, S. P. Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: Effects on RNA packaging and reverse transcription. J. Virol. 63, 319-327 (1989).
63. Bender, M. A., Palmer, T. D., Gelinas, R. E. & Miller, A. D. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61, 1639-1646 (1987).
64. Tounekti, N. et al. Effect of dimerization on the conformation of the encapsidation Ψ domain of Moloney murine leukemia virus RNA. J. Mol. Biol. 223, 205-220 (1992).
65. Mougel, M. et al. Conformational analysis of the 5′ leader and the gag initiation site of Mo-MuLV RNA and allosteric, transitions induced by dimerization. Nucleic Acids Res. 21, 4677-4684 (1993).
66. Prats, A.-C. et al. cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA. J. Virol. 64, 774-783 (1990).
67. Girard, P.-M., Bonnet-Mathoniere, B., Mauriaux, D. & Paoletti, J. A short autocomplementary sequence in the 5′ leader region is responsible for dimerization of MoMuLV genomic RNA. Biochemistry 34, 9785-9794 (1995).
68. De Tapia, M., Metzler, V., Mougel, M., Ehresmann, B. & Ehresmann, C. Dimerization of MoMuLV genomic RNA: redefinition of the role of the palindromic stem-loop H1 (278-303) and new roles for stem-loops H2 (310-352) and H3 (355-374). Biochemistry 37, 6077-6085 (1998).
69. Ly, H. & Parslow, T. G. Bipartite signal for genomic RNA dimerization in the Moloney Murine Leukemia Virus. J. Virol. 76, 3135-3144 (2002).
70. Oroudjev, E. M., Kang, P. C. E. & Kohlstaedt, L. A. An additional dimer linkage structure in Moloney Murine Leukemia Virus RNA. J. Mol. Biol. 291, 603-613 (1999).
71. Rein, A. Take two. Nature Struct. Mol. Biol. 11, 1034-1035 (2004).
72. Fisher, J. & Goff, S. P. Mutational analysis of stem-loops in the RNA packaging signal of the moloney murine leukemia virus. Virology 244, 133-145 (1998).
73. Mougel, M., Zhang, Y. & Barklis, E. cis-active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA. J. Virol. 70, 5043-5050 (1996).
74. Beasley B. E. & Hu, W. S. cis-acting elements imporant for retroviral RNA packaging specificity. J. Virol. 76, 4950-4960 (2002).
75. Evans, M. J., Bacharach, E. & Goff, S. P. RNA sequences in the Moloney murine leukemia virus genome bound by the Gag precursor protein in the yeast three-hybrid system. J. Virol. 78, 7677-7684 (2004).
76. D'Souza, V. et al. Identification of a high-affinity nucleocapsid protein binding site within the Moloney Murine Leukemia Virus Ψ-RNA packaging signal. Implications for genome recognition. J. Mol. Biol. 314, 217-232 (2001).
77. Kim, C.-H. & Tinoco Jr., I. A retroviral RNA kissing complex containing only two G-C base pairs. Proc. Natl Acad. Sci. USA 97, 9396-9401 (2000).
78. Oritz-Conde, B. A. & Hughes, S. H. Studies of the genomic RNA of leukosis viruses: implications for RNA dimerization. J. Virol. 73, 7165-7174 (1999).
79. Tchenio, T. & Heidmann, T. The dimerization/packaging sequence is dispensable for both the formation of high-molecular-weight RNA complexes within retroviral particles and the synthesis of provirus of normal structure. J. Virol. 69, 1079-1084 (1995).
80. Damgaard, C. K., Andersen, E. S., Knudsen, B., Gorodkin, J. & Kjems, J. RNA interactions in the 5′ region ofthe HIV-1 genome. J. Mol. Biol. 336, 369-379 (2004).
81. D'Souza, V. & Summers, M. F. Structural basis for packaging the dimeric genome of Moloney Murine Leukaemia Virus. Nature 431, 586-590 (2004).
82. Dey, A., York, D., Smalls-Mantey, A. & Summers, M. F. Position and sequence dependent binding of RNA to the nucleocapsid protein of Moloney Murine Leukemia Virus. Biochemistry (in the press).
83. Darlix, J.-L., Lapadat-Tapolsky, M., de Rocquigny, H. & Roques, B. P. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254, 523-537 (1995).
84. Aldovini, A. &Young, R. A. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64, 1920-1926 (1990).
85. Clavel, F. & Orenstein, J. M. A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J. Virol. 64, 5230-5234 (1990).
86. Poznansky, M., Lever, A. M. L., Bergeron, L., Haseltine, W. & Sodroski, J. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J. Virol. 65, 532-536 (1991).
87. McBride, M. S. & Panganiban, A. T. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 70, 2963-2973 (1996).
88. Harrison, G. P., Miele, G., Hunter, E. & Lever, A. M. L. Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line. J. Virol. 72, 5886-5896 (1998).
89. Kim, H.-J., Lee, K. & O'Rear, J. J. A short sequence upstream of the 5′ major splice site is important for encapsidation of HIV-1 genomic RNA. Virology 198, 336-340 (1994).
90. Luban, J, & Goff, S. P. Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. J. Virol. 68, 3784-3793 (1994).
91. Buchschacher, J., G. L. & Panganiban, A. T. Human immunodeficiency virus vectors for inducible expresson of foreign genes. J. Virol. 66, 2731-2739 (1992).
92. Parolin, C., Dorfman, t., Palu, G., Gottlinger, H. G. & Sodroski, J. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J. Virol. 68, 3888-3895 (1994).
93. Clever, J. L., Miranda, J., D. & Parslow, T. G. RNA structure and packaging signals in the 5′ leader region of the human immunodeficiency virus type 1 genome. J. Virol. 76, 12381-12387 (2002).
94. Russell, R. S., Hu, J., Laughrea, M., Wainberg, M. A. & Liang, C. Deficient dimerization of human immunodeficiency virus type 1 RNA caused by mutations of the U5 RNA sequences. Virology 303, 152-163 (2002).
95. Helga-Maria, C., Hammarskjold, M.-L. & Rekosh, D. An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type-1 genomic RNA. J. Virol. 73, 4127-4135 (1999).
96. Hayashi, T., Shioda, T., Iwakura, Y. & Shibuta, H. RNA packaging signal of human immunodeficiency virus type 1. Virology 188, 590-599 (1992).
97. Berkowitz, R. D., Hammarskjold, M.-L., Helga-Maria, C., Rekosh, D. & Goff, S. P. 5′ regions of HIV-1 RNAs are not sufficient for encapsidation: implications for the HIV-1 packaging signal. Virology 212, 718-723 (1995).
98. McBride, M. S., Schwartz, M. D. & Panganiban, A. T. Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation. J. Virol. 71, 4544-4554 (1997).
99. Baudin, F. et al. Functional sites in the 5′ region of human immunodeficiency virus type 1 RNA form defined structural domains. J. Mol. Biol. 229, 382-397 (1993).
100. Skripkin, E., Paillart, J. C. & Marquet, R., Ehresmann, B., Ehresmann, C. Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro. Proc. Natl Acad. Sci. USA 91, 4945-4949 (1994).
101. Clever, J., Sassetti, C. & Parslow, T. G. RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of Human Immunodeficiency Virus Type 1. J. Virol. 69, 2101-2109 (1995).
102. Clever, J. L. & Parslow, T. G. Mutant Human Immunodeficiency Virus type 1 genomes with defects in RNA dimerization or encapsidation. J. Virol. 71, 3407-3414 (1997).
103. Sakaguchi, K. et al. Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein. Proc. Natl Acad. Sci. USA 90, 5219-5223 (1993).
104. Dannull, J., Surovoy, A., Jung, G. & Welling, K. Specific binding of HIV- 1 nucleocapsid protein to Ψ RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J. 13, 1525-1533 (1994).
105. Berkowitz, R. D. & Goff, S. P. Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein. Virology 202, 233-246 (1994).
106. De Guzman, R. N. et al. Structure of the HIV-1 nucleocapsid protein bound to the SL3 Ψ-RNA recognition element. Science 279, 384-388 (1998).
107. Amarasinghe, G. K., De Guzman, R. N., Turner, R. B. & Summers, M. F. NMR structure of stem loop SL2 of the HIV-1 Ψ-RNA packaging signal reveals a novel A-U-A base triple platform. J. Mol. Biol. 299, 145-156 (2000).
108. Paillart, J.-C., Skripkin, E., Ehresmann, B., Ehresmann, C. & Marquet, R. A loop-loop "kissing" complex is the essential part of the dinner linkage of genomic HIV-1 RNA. Proc. Natl Acad. Sci. USA 93, 5572-5577 (1996).
109. Clever, J. L., Wong, M. L. & Parslow, T. G. Requirements for kissing-loop-mediated dimerization of human immunodeficiency virus RNA. J. Virol. 70, 5902-5908 (1996).
110. Laughrea, M. & Jette, L. A 19-nucleotide sequence upstream of the 5′ major splice donor is part of the dimerilization domain of human immunodeficiency virus 1 genomic RNA. Biochemistry 33, 13464-13474 (1994).
111. Takahashi, K.-I. et al. NMR analysis of intra- and inter-molecular stems in dimerization initiation site. J. Biochem. 127, 681-686 (2000).
112. Lawrence, D. C., Stover, C. C., Noznitsky, J., Wu, Z.-R. & Summers, M. F. Structure of the intact stem and bulge of HIV-1 Ψ-RNA stem loop SL1. J. Mol. Biol. 326, 529-542 (2003).
113. Darlix, J.-L., Gabus, C., Nugeyre, M.-T., Clavel, F. & Barre-Sinoussi, F. cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J. Mol. Biol. 216, 689-699 (1990).
114. Feng, Y.-X. et al. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc. Natl Acad. Sci. USA 93, 7577-7581 (1996).
115. Mihailescu, M.-R. & Marino, J. P. A proton-coupled dynamic conformational switch in the HIV-1 dimerization initiation site kissing complex. Proc. Natl Acad. Sci. USA 101, 1180-1194 (2004).
116. Amarasinghe, G. K. et al. NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the Ψ-RNA packaging signal. J. Mol. Biol. 301, 491-511 (2000).
117. South, T L. & Summers, M. F. Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Ψ-site analog, dACGCC. Protein Sci. 2, 3-19 (1993).
118. Clever, J. L., Taplitz, R. A., Lochrie, M. A., Polisky, B. & Parslow, T. G. A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activity. J. Virol. 74, 541-546 (2000).
119. Russell, R. S. et al. Sequences downstream of the 5′ splice donor site are required for both packaging and dimerization of human immunodeficiency virus type-1 RNA. J. Virol. 77, 84-96 (2003).
120. Amarasinghe, G. K. et al. Stem-loop SL4 of the HIV-1 Ψ-RNA packaging signal exhibits weak affinity for the nucleocapsid protein. Structural studies and implications for genome recognition. J. Mol. Biol. 314, 961-969 (2001).
121. Yu, E. & Fabris, D. Direct probing of RNA structures and RNA-protein interactions in the HIV-1 packaging signal by chemical modification and electrospray ionization-Fourier transform mass spectrometry. J. Mol. Biol. 330, 211-223 (2003).
122. Shubsda, M. F., Paoletti, A. C., Hudson, B. S. & Borer, P. N. Affinities of packaging domain loops in HIV-1 RNA for the nucleocapsid protein. Biochemistry 41, 5276-5282 (2002).
123. Hagan, N. & Fabris, D. Direct mass spectrometric determination of the stoichiometry and binding affinity of the complexes between nucleocapsid protein and RNA stem-loop hairpins of the HIV-1 Ψ-recognition element. Biochemistry 42, 10736-10745 (2003).
124. Berkhout, B. & Van Wamel, J. L. B. The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure. RNA 6, 282-295 (2000).
125. Huthoff, H. & Berkhout, B. Two alternating structures of the HIV-1 leader RNA. RNA 7, 143-157 (2001).
126. Berkhout, B. et al. In vitro evidence that the untranslated leader of the HIV-1 genome is an RNA checkpoint that regulates multiple functions through conformational changes. J. Biol. Chem. 277, 19967-19975 (2002).
127. Ooms, M., Huthoff, H., Russell, R., Liang, C. & Berkhout, B. A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J. Virol. 78, 10814-10819 (2004).
128. Paillart, J. C. et al. First snapshots of the HIV-1 RNA structure in infected cells and in virions. J. Biol. Chem. 279, 48397-48403 (2004).
129. Paillart, J. C., Skripkin, E., Ehresmann, B., Ehresmann, C. & Marquet, R. In vitro evidence for a long range pseudoknot in the 5′-untranslated and matrix coding regions of the HIV-1 genomic RNA. J. Biol. Chem. 277, 5995-6004 (2002).
130. Abbink, T. E. M. & Berkhout, B. A novel long distance base-pairing interaction in Human Immunodeficiency Virus Type 1 RNA occludes the Gag start codon. J. Biol. Chem. 278, 11601-11611 (2003).
131. McCann, E. M. & Lever, A. M. Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2. J. Virol. 71, 4544-4554 (1997).
132. Griffin, S. D. C., Allen, J. F. & Lever, A. M. The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity. J. Virol. 75, 12058-12069 (2001).
133. Arya, S. K., M., Z. & Kundra, P. Human immunodeficiency virus type 2 lentivirus for gene transfer: expression and potential for helper virus-free packaging. Hum. Gene Ther. 9, 1371-1380 (1998).
134. Poeschla, E. et al. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of non-dividing cells by HIV-2-based lentivirus vectors. J. Virol. 72, 6527-6536 (1998).
135. Dirac, A. M. G., Huthoff, H., Kjems, J. & Berkhout, B. The dimer initiation site hairpin mediates dimerization of the human immunodeficiency virus, type 2 RNA genome. J. Biol. Chem. 276, 32345-32352 (2001).
136. Lanchy, J.-M. & Lodmell, J. S. Alternate usage of two dimerization initiation sites in HIV-2 RNA in vitro. J. Mol. Biol. 319, 637-648 (2002).
137. Jossinet, F., Lodmell, J. S., Ehressmann, C., Ehresmann, B. & Marquet, R. Identification of the in vitro HIV-2/SIV RNA dimerization site reveals striking differences with HIV-1. J. Biol. Chem. 276, 5598-5604 (2001).
138. Lanchy, J.-M., Rentz, C. A., Ivanovitch, J. D. & Lodmell, J. S. Elements located upstream and downstream of the major splice donor site influence the ability of HIV-2 leader RNA to dimerize in vitro. Biochemistry 42, 2634-2642 (2003).
139. Dirac, A. M. G., Huthoff, H., Kjems, J. & Berkhout, B. Regulated HIV-2 RNA dimerization by means of alternative RNA conformations. Nucleic Acids Res. 30, 2647-2655 (2002).
140. Damgaard, C. K., Dyhr-Mikkelsen, H. & Kjems, J. Mapping the RNA binding sites for human immunodeficiency virus type-1 Gag and NC proteins within the complete HIV-1 and HIV-2 untranslated leader regions. Nucleic Acids Res. 26, 3667-3676 (1998).
141. Banks, J. D., Yeo, A., Green, K., Cepeda, F. & Linial, M. L. A minimal avian retroviral packaging sequence has a complex structure. J. Virol. 72, 6190-6194 (1998).
142. Banks, J, D,, Kealoha, B. O. & Linial, M. L. An MΨ containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles. J. Virol. 73, 8926-8933 (1999).
143. Doda-Rose, N. A. & Vogt, V. M. In vivo selection of Rous sarcoma virus mutants with randomized sequences in packaging signals. J. Virol. 72, 8073-8082 (1998).
144. Lee, E.-G. & Linial, M. L. Yeast three-hybrid screening of Rous sarcoma virus mutants with randomly mutagenized minimal packaging signals reveals regions important for Gag interactions. J. Virol. 74, 9167-9174 (2000).
145. Fosse, P. et al. A short autocomplementary sequence plays an essential role in avian sarcoma-leukosis virus RNA dimerization. Biochemistry 35, 16601-16609 (1996).
146. Lear, A. L., Haddrick, M. & Heaply, S. A study of the dimerization of the Rous sarcoma virus RNA in vitro and in vivo. Virology 212, 47-57 (1995).
147. Bieth, E., Gabus, C. & Darlix, J.-L. A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro. Nucleic Acids Res. 18, 119-127 (1990).
148. Parent, L. J. et al. RNA dimerization defect in a Rous sarcoma virus matrix mutant. J. Virol. 74, 164-172 (2000).
149. Garbitt, R. A., Albert, J. A., Kessler, M. D. & Parent, L. J. trans-acting inhibition of genomic RNA dimerization by Rous sarcoma virus matrix mutants. J. Virol. 75, 260-268 (2001).
150. Kemler, I., Barraza, R. & Poeschla, E. Mapping of the encapsidation determinants of feline immunodeficiency virus. J. Virol. 76, 11889-11903 (2002).
151. Mansky, L. M. & Galary, L. C. The primary nucleotide sequence of the bovine leukemia virus RNA packaging signal can influence efficient RNA packaging and virus replication. J. Virol. 301, 272-280 (2002).
152. Katoh, I., Kyushiki, H., Sakamoto, Y, Ikawa, Y. & Yoshinaka, Y. Bovine leukemia virus matrix-associated protein MA(p15): further processing and formation of a specific complex with the dinner of the 5′-terminal genomic RNA fragment. J. Virol. 65, 61545-6855 (1991).
153. Vile, R. G., Ali, M., Hunter, e. & McClure, M. O. Identification of a generalized packaging sequence for D-type retroviruses and generation of a D-type retroviral vector. Virology 189, 786-791 (1992).
154. Harrison, G. P., Hunter, E. & Lever, A. M. L. Secondary structure model of the Mason-Pfizer monkey virus 5′ leader sequence: identification of a structural motif common to a variety of retroviruses. J. Virol. 69, 2175-2186 (1995).
155. Schmidt, R. D., Mustafa, F., KLew, K. A., Browning, M. T. & Rizvi, T. A. Sequences both within the 5′ untranslated region and the gag gene are important for efficient encapsidation of Mason-Pfizer monkey virus RNA. Virology 309, 166-178 (2003).
156. Ma, Y. M. & Vogt, V. M. Nucleic acid binding-induced Gag dimerization in the assembly of Rous sarcoma virus particles in vitro. J. Virol. 78, 52-60 (2004).
157. Yu, F. et al. Characterization of Rous sarcoma virus Gag particles assembled in vitro. J. Virol. 75, 2753-2764 (2001).
158. Muriaux, D., Mirro, J., Nagashima, K., Harvin, D. & Rein. A. Murine leukemia virus nucleocapsid mutant particles lacking viral RNA encapsidate ribosomes. J. Virol. 76, 11405-11413 (2002).
159. Aronoff, R. & Linial, M. Specificity of retroviral RNA packaging. J. Virol. 65, 71-80 (1991).
160. Linial, M., Medeiros, E. & Hayward, W. S. An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization. Cell 15, 1371-1381 (1978).
161. Dupont, S. et al. A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature 402, 681-6135 (1999).
162. Scheifele, L. Z., Garbitt, R. A., Rhoads, J. D. & Parent, L. J. Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein. Proc. Natl Acad. Sci. USA 99, 3944-3949 (2002).
163. Callahan, E. M. & Wills, J. W. Link between genome packaging and rate of budding for Rous Sarcoma Virus. Virology 77, 9388-9398 (2003).
164. Nash, M. A., Meyer, M. K., Decker, G. L. & Arlinghaus, R. B. A subset of Pr65gag is nucleus associated in Murine Leukemia Virus-infected cells. J. Virol. 67, 1350-1356 (1993).
165. Basyuk, E. et al. Retroviral genomic RNAs are transported to the plasma membrane by endosomal vesicles. Dev. Cell 5, 161-174 (2003).
166. D'Souza, V, Dey, A., Habib, D. & Summers, M. F. NMR structure of the 101 nucleotide core encapsidation signal of the Moloney Murine Leukemia Virus. J. Mol. Biol. 337, 427-442 (2004).